http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0584314-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49f04b1dc6b9fcc2d8b159c5ebee364b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-20
filingDate 1991-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62c26cfde965fa4fbd2e5d6802ff7bbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6258bceff1a5edab3a933b1f963511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c9a846dd3df346b04d82f19c18c990
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf01c7f1b9ed8471fb64f9c06310714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22ceb5d2e2da3e07387f539f7f1d33c8
publicationDate 1993-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0584314-A
titleOfInvention Vascular treatment device
abstract (57) [Summary] [Object] An object of the present invention is to provide a vascular treatment device that is less dangerous and that can effectively and reliably calm vasospasm. [Structure] The laser light output from the solid-state laser 1 is given to the harmonic generator 1a, and 532 nm, 355 nm, etc. are obtained in addition to the fundamental wavelength of 1064 nm. Wavelength selector 1b Selects a wavelength of 532 nm, and the optical wavelength converter 2 and the second optical wavelength converter 2a convert it into wavelengths of 700 to 600 nm and 400 to 600 nm. The converted light is further screened by the second wavelength selector 3 to select only 550 nm. This laser light is shaped by the beam shaper 5 and is applied to the spasm blood vessel 6. The blood vessel width measuring device 9 calculates the expansion rate of the blood vessel 6 and the blood flow rate. The expansion state is monitored in real time based on this expansion rate, and the oscillation output of the solid-state laser 1 is feedback-controlled.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6011809-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008226754-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0938101-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7008414-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005095521-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020008657-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0178632-A1
priorityDate 1991-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544408

Total number of triples: 23.